Cardiovascular Players Could Be Eyeing Esperion By: Benzinga via Benzinga April 10, 2017 at 11:53 AM EDT Takeover chatter prompted a 5.5 percent spike in Esperion Therapeutics Inc (NASDAQ: ESPR) Monday. A source familiar with the matter ... Read More >> Related Stocks: Astrazeneca Plc ADR Esperion Theraptc Merck & Co Pfizer Sanofi-Aventis S.A. ADR